Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Complete Response Letter from FDA on Intermezzo® New Drug Application
Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Complete Response Letter from FDA on Intermezzo® New Drug Application
Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Complete Response Letter from FDA on Intermezzo® New Drug Application
Submitted by
admin
on July 16, 2011 - 11:43am
Source:
Yahoo/PR NewsWire
News Tags:
Transcept
Intermezzo
insomnia
Headline:
Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Complete Response Letter from FDA on Intermezzo® New Drug Application
Do Not Allow Advertisers to Use My Personal information
